drugset / Trial / NCT07413666
A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
RandomizedParallel-groupDouble-blindTreatment
Summary
Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.
Timeline
- Start
- 2026-02-25
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ORX489 | Unknown | — | — |
Indications
No indication recorded.